Study of genetic diversity, biofilm formation, and detection of Carbapenemase, MBL, ESBL, and tetracycline resistance genes in multidrug-resistant


Journal

Antimicrobial resistance and infection control
ISSN: 2047-2994
Titre abrégé: Antimicrob Resist Infect Control
Pays: England
ID NLM: 101585411

Informations de publication

Date de publication:
2019
Historique:
received: 13 07 2019
accepted: 21 09 2019
entrez: 14 11 2019
pubmed: 14 11 2019
medline: 8 7 2020
Statut: epublish

Résumé

Antimicrobial resistance in multidrug-resistant In this cross-sectional research, 163 non-repetitive Among 163 Results of the present study show that antimicrobial resistance in CNSAB isolates from burn wound infections in monitored hospitals in Iran is multifactorial, and also findings of the study suggested that local antibiotic prescription policies should be regularly reviewed, and efficient infection control measures should be observed. Therefore, further strengthening of surveillance of antimicrobial resistance is urgently needed in these regions.

Sections du résumé

Background
Antimicrobial resistance in multidrug-resistant
Methods
In this cross-sectional research, 163 non-repetitive
Results
Among 163
Conclusions
Results of the present study show that antimicrobial resistance in CNSAB isolates from burn wound infections in monitored hospitals in Iran is multifactorial, and also findings of the study suggested that local antibiotic prescription policies should be regularly reviewed, and efficient infection control measures should be observed. Therefore, further strengthening of surveillance of antimicrobial resistance is urgently needed in these regions.

Identifiants

pubmed: 31719975
doi: 10.1186/s13756-019-0612-5
pii: 612
pmc: PMC6836547
doi:

Substances chimiques

Anti-Bacterial Agents 0
Bacterial Proteins 0
beta-Lactamases EC 3.5.2.6
carbapenemase EC 3.5.2.6

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

172

Informations de copyright

© The Author(s). 2019.

Déclaration de conflit d'intérêts

Competing interestsThe authors declare that they have no competing interests.

Références

Sci Rep. 2018 May 8;8(1):7289
pubmed: 29740176
Antimicrob Agents Chemother. 2006 Dec;50(12):4114-23
pubmed: 17000742
Infect Genet Evol. 2019 Jul;71:60-66
pubmed: 30902743
J Infect Dev Ctries. 2012 Nov 26;6(11):757-62
pubmed: 23277500
Acta Clin Croat. 2019 Mar;58(1):113-118
pubmed: 31363333
Infect Drug Resist. 2018 Nov 15;11:2277-2299
pubmed: 30532562
Int J Microbiol. 2017;2017:3925868
pubmed: 28567057
MBio. 2019 Jul 16;10(4):null
pubmed: 31311879
Asian Pac J Trop Med. 2015 Jun;8(6):438-46
pubmed: 26194827
J Chin Med Assoc. 2017 Apr;80(4):245-252
pubmed: 28268175
J Microbiol Methods. 2005 Aug;62(2):221-32
pubmed: 16009279
Indian J Pathol Microbiol. 2013 Jul-Sep;56(3):276-8
pubmed: 24152509
Antimicrob Agents Chemother. 2011 Mar;55(3):1285-6
pubmed: 21199925
Saudi J Biol Sci. 2015 Jul;22(4):424-9
pubmed: 26150748
Indian J Med Microbiol. 2015 Jan-Mar;33(1):87-91
pubmed: 25560008
Scientifica (Cairo). 2014;2014:245162
pubmed: 25133013
Clin Microbiol Infect. 2012 Mar;18(3):268-81
pubmed: 21793988
J Glob Antimicrob Resist. 2018 Dec;15:154-163
pubmed: 29859266
Ann Clin Microbiol Antimicrob. 2017 Nov 2;16(1):70
pubmed: 29096652
Diagn Microbiol Infect Dis. 2011 May;70(1):119-23
pubmed: 21398074
Ann Clin Microbiol Antimicrob. 2017 Jul 19;16(1):51
pubmed: 28724383
Antimicrob Agents Chemother. 2014;58(1):297-303
pubmed: 24165187
Microb Pathog. 2017 Jul;108:122-128
pubmed: 28457900
APMIS. 2017 Nov;125(11):1017-1026
pubmed: 28913903
Antimicrob Resist Infect Control. 2019 May 22;8:80
pubmed: 31139363
Rev Soc Bras Med Trop. 2016 Jul-Aug;49(4):433-40
pubmed: 27598629
Antimicrob Agents Chemother. 2017 Sep 22;61(10):
pubmed: 28739789
J Glob Antimicrob Resist. 2018 Mar;12:107-112
pubmed: 28986323
Asian Pac J Trop Biomed. 2013 Feb;3(2):140-5
pubmed: 23593593
J Microbiol Methods. 2018 Dec;155:19-23
pubmed: 30423363
Antimicrob Agents Chemother. 2013 May;57(5):2121-6
pubmed: 23439638
Indian J Med Res. 2019 Feb;149(2):240-246
pubmed: 31219089

Auteurs

Reza Ranjbar (R)

1Molecular Biology Research Center, Systems Biology and Poisonings Institute, Baqiyatallah University of Medical Sciences, Tehran, Iran.

Abbas Farahani (A)

2Infectious and Tropical Diseases Research Center, Hormozgan Health Institute, Hormozgan University of Medical Sciences, Bandar Abbas, Iran.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH